Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125263012 | 12526301 | 2 | F | 201011 | 20160912 | 20160705 | 20160914 | PER | US-PFIZER INC-3057855 | PFIZER | 57.00 | YR | F | Y | 0.00000 | 20160914 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125263012 | 12526301 | 1 | PS | XELJANZ | TOFACITINIB CITRATE | 1 | UNK | U | UNK | 203214 | TABLET | ||||||||
| 125263012 | 12526301 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | 17.5 MG (7 X 2.5 MG TABLETS) WEEKLY (7 PILLS A DAY EVERY WEEK) | Y | 0 | 17.5 | MG | TABLET | /wk | ||||||
| 125263012 | 12526301 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | 20 MG (8 TABLETS) WEEKLY | Y | 0 | 20 | MG | TABLET | /wk | ||||||
| 125263012 | 12526301 | 4 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | UNK (EVERY 8 WEEK) | Y | 0 | INJECTION | ||||||||
| 125263012 | 12526301 | 5 | C | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | 200 MG, 2X/DAY | 0 | 200 | MG | BID | ||||||||
| 125263012 | 12526301 | 6 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | HYDROCODONE BITARTRATE 5 MG, PARACETAMOL 325 MG | 0 | |||||||||||
| 125263012 | 12526301 | 7 | C | DARVOCET-N 100 | ACETAMINOPHENPROPOXYPHENE NAPSYLATE | 1 | 100 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125263012 | 12526301 | 1 | Rheumatoid arthritis |
| 125263012 | 12526301 | 2 | Rheumatoid arthritis |
| 125263012 | 12526301 | 4 | Rheumatoid arthritis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125263012 | 12526301 | Malaise | |
| 125263012 | 12526301 | Tooth disorder | |
| 125263012 | 12526301 | Tooth loss |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125263012 | 12526301 | 2 | 200509 | 201012 | 0 | |
| 125263012 | 12526301 | 3 | 2009 | 201206 | 0 | |
| 125263012 | 12526301 | 4 | 200106 | 200612 | 0 | |
| 125263012 | 12526301 | 5 | 2007 | 2014 | 0 | |
| 125263012 | 12526301 | 6 | 2010 | 2015 | 0 | |
| 125263012 | 12526301 | 7 | 2006 | 0 |